Author response to "lack of benefit from low dose computed tomography in screening for lung cancer"

BMC Pulm Med. 2020 Aug 26;20(1):226. doi: 10.1186/s12890-020-01247-y.

Abstract

We explain to Dr. Benjamin (corresponding author) about why low-dose computed tomography reduce lung cancer mortality without significantly reducing all-cause mortality. We also conduct an up-to-date meta-analysis to evaluate low-dose computed tomography clinical effectiveness compared with usual care of lung cancer screening.

Keywords: LDCT; Low-dose computed tomography; Lung cancer screening; Meta-analysis; Mortality.

Publication types

  • Letter
  • Comment

MeSH terms

  • Early Detection of Cancer*
  • Humans
  • Lung Neoplasms*
  • Mass Screening
  • Tomography, X-Ray Computed
  • Treatment Outcome